Alvotech
20-F
March 31, 2026
Key Highlights
- Achieved first-ever annual profit of $27.9 million in 2025, signaling a successf...
- Generated $350 million in revenue driven by the successful U.S. launch of Simlan...
- Secured marketing approvals for key biosimilar products across more than 30 coun...
Read Analysis
🤖 AI Generated